Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Novo Nordisk A/S (NYSE:NVO)

48.80
Delayed Data
As of Feb 12
 +0.18 / +0.37%
Today’s Change
42.68
Today|||52-Week Range
60.34
-15.98%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Quarter
Trend
Quarter 1
2015
Quarter 2
2015
Quarter 3
2015
Quarter 4
2015
AssetsCash860.3M1.8B2.3B2.5B
 
 
 
 
 
Short Term Investment Cash-1.2B847.9M558.4M146.2M
 
 
 
 
 
Cash & Short Term Investments1.1B1.8B2.7B3.0B
 
 
 
 
 
 
ReceivablesReceivables3.1B2.9B2.7B2.8B
 
 
 
 
 
 
InventoriesInventories1.8B1.9B1.9B1.9B
 
 
 
 
 
 
Current AssetsOther Current Assets353.6M451.4M422.9M328.5M
 
 
 
 
 
Current Assets6.2B7.1B7.7B8.0B
 
 
 
 
 
 
Total AssetsIntangible Assets197.2M218.1M219.2M314.1M
 
 
 
 
 
Other Assets197.2M218.1M219.2M314.1M
 
 
 
 
 
Total Assets11.1B12.1B12.7B13.4B
 
 
 
 
 
 
LiabilitiesAccounts Payable577.1M587.3M575.3M717.2M
 
 
 
 
 
Short Term Debt85.4M109.9M94.3M156.2M
 
 
 
 
 
Other Current Liabilities4.9B4.6B4.6B5.0B
 
 
 
 
 
Other Liabilities6.0B5.8B5.8B5.9B
 
 
 
 
 
 
Total LiabilitiesDeferred Taxes-1.0B-992.0M-923.8M-989.8M
 
 
 
 
 
Other Liabilities0.000.000.000.00
 
 
Total Liabilities6.5B6.3B6.3B6.5B
 
 
 
 
 
 
EquityMinority Interest0.000.000.00----
Preferred Stock0.000.000.00----
Common Equity4.6B5.8B6.5B6.8B
 
 
 
 
 
Total Shareholder Equity4.6B5.8B6.5B6.8B
 
 
 
 
 
 
Share InformationCommon Shares Outstanding2.1B2.1B2.1B--
 
 
 
 
 
Addtl. Info.No data currently available for this section.